Ophthalmology News

ATSN-201 received orphan drug designation from the FDA for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

ANI Pharmaceuticals finalized its acquisition of Alimera Sciences, according to a press release.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Richard Lewis, MD, speaks about femtosecond laser image-guided high-precision trabeculotomy, or FLigHT.

While there are currently no FDA-approved pharmacological therapies for the treatment of cataracts, an eye drop demonstrated promising vision improvements in patients with early-stage cataracts in a phase 1/2 clinical trial.

In this video, Barbara Blodi, MD, discusses long-term data on geographic atrophy growth rates in treatment-naive patients with age-related macular degeneration.

BARCELONA, Spain — ESCRS guidelines for refractive surgery are a work in progress, expected to be released in 2025. Experts are using a structured methodology, but there are challenges and many unanswered questions.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Dan Z. Reinstein, MD, speaks about hyperopic SMILE with the VisuMax 800 excimer laser from Carl Zeiss Meditec.

Saving money at an early age is perhaps the simplest and one of the most effective methods to accumulate wealth.

Well, hi, I'm Kara Pepper. I'm a primary care internist in Atlanta, Georgia.

BARCELONA, Spain — In this Healio Video Perspective from the European Society of Cataract and Refractive Surgeons meeting, Jorge L. Alió, MD, PhD, speaks about the physical principles of extended depth of focus lenses.